An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabine/Retigabine (NAMR) Will Also be Assessed
Clinical trial NCT01583036 · COMPLETED
Trial details
- NCT number
- NCT01583036
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-16
- Primary completion
- 2012-04-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.